THESEUS PHARMACEUTICALS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2021-02-04: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-01-22; Total offering amount $100,099,954.
- 2021-02-04: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-06-14; Total offering amount $22,136,987.
- 2018-06-29: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-06-14; Total offering amount $15,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2021-02-04 | Rule 506(b) | Equity | 2021-01-22 | $100,099,954 | $95,099,957 | $4,999,997 | 16 |
| 2021-02-04 D/A | Rule 506(b) | Equity | 2018-06-14 | $22,136,987 | $22,136,987 | $0 | 3 |
| 2018-06-29 | Rule 506(b) | Equity | 2018-06-14 | $15,000,000 | $5,000,000 | $10,000,000 | 3 |